Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
It is a new formulation of methylene blue, an old product. More than two years ago, British scientists reported a new drug that was designed to slow Alzheimer’s disease. The trial involved 321 people with mild to moderate Alzheimer’s in the United Kingdom and Singapore. The patients were divided into four groups, three of which took different doses of Rember, and the fourth was provided a placebo. Following testing, those in the first three groups experienced an 81 percent decrease in symptoms, while those taking the placebo worsened. The drug was developed to target and dissolve “tangles” in the brain that destroy nerve cells and lead to memory deterioration. While this (and other drugs) cannot reverse the devastating effects of Alzheimer’s, it appeared to stabilize it. Results suggest the drug is almost 2-1/2 times more effective than existing drugs currently on the market.
The results of the study were presented at the International Conference on Alzheimer’s in Chicago and have been touted as the most realistic evidence that a new drug can improve cognition in people with the disease. It brings new hope to both sufferers and their caregivers.
A consulting psychiatrist monitored the program and indicated those on Rember were more confident and better able to cope with daily activity and didn’t experience the level of mental decline expected. The trial was a Phase 2 study that was geared toward checking the safety and efficacy of the drug. If the results of future studies are as promising as indicated in this study, the medication might be made available for prescribing. The drug is still in the trial stages, with more testing to go before it might — and I say might — become available by prescription. A major and perhaps insurmountable concern is funding. The cost of Aricept for the treatment of Alzheimer’s is about $9 per pill. However, when we compare the cost of home health, nursing facilities and hospitalizations, the study might be on the right track. Read more: newssun.suntimes.com
Calcium + vitamin-D shows bone boosting benefits for teenage girls
Supplements of calcium and vitamin D may boost the bone health of girls undergoing puberty, and potentially reduce the risk of osteoporosis later in life, suggests a new study from Down Under. Read more: nutraingredients.com
No comments:
Post a Comment